title: Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance.
abstract: BACKGROUND
  Both the amount and quality of dietary fat can modify glucose and insulin metabolism.
  
  
  OBJECTIVE
  The objective was to examine the relation between serum lipid fatty acids and glucose metabolism before and after the consumption of a diet enriched in either monounsaturated (Mono diet) or polyunsaturated (Poly diet) fatty acids.
  
  
  METHODS
  After consuming a high-saturated-fat run-in diet for 3 wk, 31 subjects with impaired glucose tolerance were randomly counseled to consume the Mono [40% fat; 11%, 19%, and 8% of energy as saturated, monounsaturated, and polyunsaturated fatty acids (S:M:P), respectively] or the Poly (34% fat; S:M:P of 11%:10%:10%) diet for 8 wk. Serum lipid fatty acids were measured, and an intravenous-glucose-tolerance test was performed at baseline and at 8 wk.
  
  
  RESULTS
  At baseline, a higher glucose effectiveness (S(G)) was associated with higher proportions of oleic (r = 0.57, P = 0.04) and alpha-linolenic (r = 0.64, P = 0.01) acids in phospholipids. An increase in the proportions of oleic and alpha-linolenic acids in phospholipids was associated with a decrease in fasting plasma glucose [r = -0.53 (P = 0.002) and r = -0.47 (P = 0.009), respectively]. An increase in the S(G) was associated with an increase in the proportion of oleic acid (r = 0.55, P = 0.004) and with a decrease in that of arachidonic acid (r = -0.40, P = 0.04) in phospholipids.
  
  
  CONCLUSIONS
  The beneficial changes in fasting plasma glucose and in the S(G) during the Mono diet were associated with alterations in the proportions of oleic, alpha-linolenic, and arachidonic acids in phospholipids.
authors.affiliation: Department of Clinical Nutrition, University of Kuopio, Finland. anne.louheranta@uku.fi
authors.forename: Anne M
authors.initials: AM
authors.lastname: Louheranta
authors.forename: Essi S
authors.initials: ES
authors.lastname: Sarkkinen
authors.forename: Helvi M
authors.initials: HM
authors.lastname: Vidgren
authors.forename: Ursula S
authors.initials: US
authors.lastname: Schwab
authors.forename: Matti I J
authors.initials: MI
authors.lastname: Uusitupa
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D004041:Dietary Fats / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005229:Fatty Acids, Monounsaturated / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged
chemical_list: D001786:Blood Glucose; D004041:Dietary Fats; D005229:Fatty Acids, Monounsaturated; D005231:Fatty Acids, Unsaturated; D007328:Insulin; D008055:Lipids